Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine.

Yenilmez, Ebru Dundar; Tamam, Lut; Karaytug, Onur; Tuli, Abdullah

Yenilmez, Ebru Dundar; Tamam, Lut; Karaytug, Onur; Tuli, Abdullah.

Yenilmez ED; Medical Biochemistry, Faculty of Medicine, University of Cukurova, Adana, Turkey.
Tamam L; Medical Biochemistry, Faculty of Medicine, University of Cukurova, Adana, Turkey.
Karaytug O; Psychiatry, Faculty of Medicine, University of Cukurova, Adana, Turkey.
Tuli A; Psychiatry, Faculty of Medicine, University of Cukurova, Adana, Turkey.

Comb Chem High Throughput Screen ; 21(5): 374-380, 2018.

Article en En | MEDLINE | ID: mdl-29921201

Asunto(s)

Hidrocarburo de Aril Hidroxilasas/metabolismo; Trastorno Bipolar/metabolismo; Esquizofrenia/metabolismo; Frecuencia de los Genes/genética; Genotipo; Humanos; Polimorfismo Genético/genética; Medicina de Precisión/métodos; Psiquiatría/métodos

Palabras clave

CYP450 polymorphism; HRMA; bipolar disease; drug dosage adjustment; pharmacogenetic; schizophrenia.

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Trastorno Bipolar / Hidrocarburo de Aril Hidroxilasas Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google